Evidence map›Paper›PMID 42651731›Full record

ArticleBiology2026

NARVGA: A Hybrid Framework Integrating Matrix Factorisation and Adversarial Graph Learning for circRNA-Disease Association Prediction.

Mian-Shuo Lu, Meng-Meng Wei, Chang-Chun Liu, Lei Wang, Cheng-Wei Ruan

Abstract read
In one paragraph

Article in Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mian-Shuo LuGuangxi Key Lab of Human-Machine Interaction and Intelligent Decision, Guangxi Academy of Sciences, Nanning 530007, China.
Meng-Meng WeiSchool of Computer Science and Technology/School of Artificial Intelligence, China University of Mining and Technology, Xuzhou 221116, China.ORCID 0009-0009-9453-7653
Chang-Chun LiuSchool of Computer Science and Technology/School of Artificial Intelligence, China University of Mining and Technology, Xuzhou 221116, China.
Lei WangGuangxi Key Lab of Human-Machine Interaction and Intelligent Decision, Guangxi Academy of Sciences, Nanning 530007, China.
Cheng-Wei RuanDepartment of Anorectal Surgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221006, China.ORCID 0000-0003-3893-6763

Funding

National Natural Science Foundation of China 62325308National Natural Science Foundation of China 62573419
6 · The paper itself

Abstract

Circular RNAs (circRNAs) participate in gene regulation and disease progression, but experimental mapping of circRNA-disease associations (CDAs) remains costly and incomplete. We developed NARVGA, a hybrid prediction framework that combines non-negative matrix factorisation (NMF) with an adversarially regularised variational graph autoencoder (ARVGA). Functional, semantic and Gaussian interaction-profile kernel similarities are integrated; K-means-derived co-membership graphs reduce diffuse similarity connections; ARVGA learns nonlinear topological embeddings; and NMF captures complementary low-rank association patterns. An Extra Trees classifier then scores candidate circRNA-disease pairs. In the original transductive stratified five-fold benchmark on CircR2Disease, NARVGA achieved an area under the receiver operating characteristic curve (AUC) of 0.9868, an area under the precision-recall curve (AUPR) of 0.9887, 94.32% accuracy and a 94.44% F1-score. Ablation analysis identified cluster sparsification as the largest individual contributor, with additional gains from adversarial regularisation and low-rank augmentation. Without task-specific retuning, the model obtained AUCs of 0.9503 on LncRNADisease and 0.9700 on HMDDv4. Performance was stable across GCN depths and cluster settings, and 19 of the 20 highest-ranked hepatocellular carcinoma candidates had supporting published evidence. NARVGA provides a within-network prioritisation tool for RNA-disease association studies, although prospective validation, hard-negative assessment and independent-cohort testing remain necessary.

Indexed as

adversarially regularised variational graph autoencoderbiological link predictioncircRNA-disease association predictiongraph representation learningnon-negative matrix factorisation

Identifiers

PMID42651731
PMCPMC13509260

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.